Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B.

Honorati MC, Palareti A, Dolzani P, Busachi CA, Rizzoli R, Facchini A.

Clin Exp Immunol. 1999 Apr;116(1):121-6.

2.

Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.

Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, Lu J, Sun Z, Qu C.

Vaccine. 2011 Oct 13;29(44):7835-41. doi: 10.1016/j.vaccine.2011.07.098. Epub 2011 Aug 2.

PMID:
21816197
3.

Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years.

Da Villa G, Peluso F, Picciotto L, Bencivenga M, Elia S, Pelliccia MG.

Vaccine. 1996 Nov;14(16):1503-5.

PMID:
9014290
4.

Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine.

Da Villa G, Pelliccia MG, Peluso F, Ricciardi E, Sepe A.

Res Virol. 1997 Mar-Apr;148(2):109-14.

PMID:
9108609
5.

Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.

Jafarzadeh A, Montazerifar SJ.

J Ayub Med Coll Abbottabad. 2006 Oct-Dec;18(4):4-9.

PMID:
17591001
6.

Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.

Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C.

Am J Gastroenterol. 2012 Jan;107(1):133-8. doi: 10.1038/ajg.2011.295. Epub 2011 Aug 30.

PMID:
21876562
7.

The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.

Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F.

Hum Vaccin. 2011 Oct;7(10):1055-9. doi: 10.4161/hv.7.10.15990. Epub 2011 Oct 1.

PMID:
21989290
8.

[Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].

Roznovský L, Tvrdík J, Kabieszová L, Petrousová L, Orságová I, Hozáková L, Lochman I, Kloudová A, Valkovský I, Letocha P, Schwarzová S, Hladík M, Zjevíková A.

Vnitr Lek. 2011 Oct;57(10):808-14. Czech.

PMID:
22097688
9.

[Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].

Xia G, Jia Z, Yan T, Li R, Liu H, Xu Z, Cao H, Liu C.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002 Jun;16(2):146-9. Chinese.

PMID:
12196826
10.

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Young MD, Gooch WM 3rd, Zuckerman AJ, Du W, Dickson B, Maddrey WC.

J Med Virol. 2001 Jul;64(3):290-8.

PMID:
11424117
11.

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.

Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.

Pediatr Infect Dis J. 2008 Oct;27(10):881-5. doi: 10.1097/INF.0b013e31817702ba.

PMID:
18756185
12.

Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules.

Agladioglu S, Beyazova U, Camurdan AD, Sahin F, Atak A.

Infection. 2010 Aug;38(4):269-73. doi: 10.1007/s15010-010-0031-2. Epub 2010 May 29.

13.

[Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].

Chlibek R, Smetana J, Bostíková V, Splino M.

Epidemiol Mikrobiol Imunol. 2011 Sep;60(3):99-108. Czech.

PMID:
22132651
14.

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.

Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.

Vaccine. 2012 Jun 8;30(27):4034-9. doi: 10.1016/j.vaccine.2012.04.031. Epub 2012 Apr 22.

PMID:
22531558
16.

Persistence of anti-HBs and protective efficacy after administration of hepatitis B vaccine.

Yoshida K, Fujiyama S, Sato T.

J Gastroenterol Hepatol. 1990 Mar-Apr;5(2):126-9.

PMID:
2151729
17.

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.

Heijtink RA, van Bergen P, Paulij WP, de Man RA, Osterhaus AD.

Vaccine. 2000 Feb 14;18(15):1531-8.

PMID:
10618551
18.

Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.

McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW.

J Infect Dis. 2009 Nov 1;200(9):1390-6. doi: 10.1086/606119.

PMID:
19785526
19.

Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.

Douvin C, Simon D, Charles MA, Deforges L, Bierling P, Lehner V, Budkowska A, Dhumeaux D.

Diabetes Care. 1997 Feb;20(2):148-51.

PMID:
9118762
20.

Hepatitis B vaccination in preterm infants.

Gołebiowska M, Kardas-Sobantka D, Chlebna-Sokół D, Sabanty W.

Eur J Pediatr. 1999 Apr;158(4):293-7.

PMID:
10206126

Supplemental Content

Support Center